Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine with or without triamcinolone for ilioinguinal nerve block after herniorrhaphy
IRCT20241012063337N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ropivacaine and triamcinolone in postoperative pain (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Amount of pain and Duration of return to activity. Started Oct 2024; status: completed.
02
Drugs
ropivacainetriamcinolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20241012063337N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241012063337N1.